Aperio Raises $10.6 Million to Fuel Growth in Digital Pathology
Summary
VISTA, Calif.--(BUSINESS WIRE)--Aperio Technologies, Inc., the leading provider of digital pathology systems and services to the healthcare and life sciences industry, is pleased to announce that it has closed a $10.6 million round of financing. “Based on the benefits derived by the existing customer base, including increased efficiency, cost savings, and improved patient care, we believe Aperio will continue to dominate and lead this space with its pivotal technology.” Zubeen Shroff, general partner at Galen, commented that, “Aperio has done a terrific job in scaling its operations to address increasing customer demand. With more than 25 years of experience, ATV has a proven track record of success in helping to build strong, sustainable business enterprises. Galen Partners is a private equity firm, founded in 1990 and focused exclusively on financing mid-to-later stage growth companies in the healthcare industry. Galen’s approach, called Collaborative Capital, enables them to work with company management to create disruptive strategies that generate revenue growth and help achieve full market potential.
Funding
Classifications
AskAI Classifications
LabelsLinked Companies
